Israel Gives First Green Light to Medical Marijuana for Export
![](https://images.forwardcdn.com/image/970x/center/images/cropped/w-israelmarijuana-13014-1423643497.jpg)
Image by getty images
An Israeli government committee gave an initial nod on Sunday for the export of medical marijuana in what could be a windfall for companies in Israel, widely regarded as a leader in research in the field.
A government statement announcing the vote said it could take months for the legislation to make its way through parliament.
In the United States, 28 states have legalized marijuana for medical use and since 2012, Colorado, Alaska, California, Maine, Massachusetts, Nevada, Oregon and Washington, D.C. have also approved marijuana for recreational use. The market there, by some estimates, will reach $50 billion over the next decade.
Israel is widely regarded as one of the world leaders in medical marijuana research, even though the local market is small. Only 23,000 people have Health Ministry permits to purchase medical cannabis from nine licensed suppliers, creating a market of $15 million to $20 million at most.
Saul Kaye, CEO of iCAN, a private cannabis research hub in Israel, said there are about 50 Israeli medical marijuana companies active in many aspects of the industry, from agriculture to delivery devices, such as inhalers.
Kaye estimated that international investments in Israeli companies reached about $100 million in 2016.
A message from our editor-in-chief Jodi Rudoren
![](https://forward.com/wp-content/uploads/2024/07/Jodi-Headshot.jpg)
We're building on 127 years of independent journalism to help you develop deeper connections to what it means to be Jewish today.
With so much at stake for the Jewish people right now — war, rising antisemitism, a high-stakes U.S. presidential election — American Jews depend on the Forward's perspective, integrity and courage.
— Jodi Rudoren, Editor-in-Chief